Left Atrial Appendage Closure in Patients With Contraindications to Oral Anticoagulation
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F16%3A%230006959" target="_blank" >RIV/00023884:_____/16:#0006959 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Left Atrial Appendage Closure in Patients With Contraindications to Oral Anticoagulation
Original language description
The PROTECT AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) and PREVAIL (Prospective Randomized Evaluation of the Watchman LAA Closure Device In Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy) trials revealed that in atrial fibrillation (AF) patients suitable for oral anticoagulation (OAC), mechanical left atrial appendage closure (LAAC) with a catheter-delivered heart implant device (Watchman; Boston Scientific, Marlborough, Massachusetts) is effective for stroke prevention 1 and 2. Importantly, these patients received at least 6 weeks of OAC. Although there is no randomized LAAC trial in OAC-contraindicated patients, there is 1 prospective nonrandomized study of Watchman in these patients (n = 150; CHA2DS2-VASc [Congestive heart failure; Hypertension; Age; Diabetes mellitus; prior Stroke, TIA, or thromboembolism; Vascular disease; Age; Sex category {female}] score = 4.4) (3). In this trial, ASAP (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology), the post-implantation annual ischemic stroke rate was 1.7%, representing 77% fewer strokes than expected for this population. Although promising, the mean follow-up in ASAP was only 1.2 years, so there have been few long-term data regarding LAAC in OAC-contraindicated patients. Herein, we report the 5-year follow-up of ASAP.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of the American College of Cardiology
ISSN
0735-1097
e-ISSN
—
Volume of the periodical
67
Issue of the periodical within the volume
18
Country of publishing house
US - UNITED STATES
Number of pages
3
Pages from-to
2190-2192
UT code for WoS article
000375406100016
EID of the result in the Scopus database
2-s2.0-84966526573